Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
4
Halozyme Therapeutics
HALO
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | 113.38%162M | 117.29%156M | 56.49%-114M | 364.06%297M | -59.46%-177M | -227.30%-1.21B | ---902M | ---262M | --64M | ---111M |
Deferred tax | -163.64%-348M | -571.43%-231M | -409.09%-34M | 55.70%-35M | 57.52%-48M | 8.97%-132M | --49M | --11M | ---79M | ---113M |
Other non cash items | 120.30%586M | 120.35%249M | 707.41%164M | -146.32%-44M | 155.29%217M | 3,225.00%266M | --113M | ---27M | --95M | --85M |
Change In working capital | -380.00%-98M | -19.02%149M | -113.14%-36M | -19.05%-225M | 105.98%14M | -88.52%35M | --184M | --274M | ---189M | ---234M |
-Change in receivables | -147.83%-11M | -70.00%-17M | 28.57%-10M | -250.00%-3M | -57.78%19M | 291.67%23M | ---10M | ---14M | --2M | --45M |
-Change in prepaid assets | -127.59%-40M | -134.57%-56M | 250.00%18M | -200.00%-2M | 116.25%13M | 185.80%145M | --162M | ---12M | --2M | ---80M |
-Change in other current assets | 155.50%212M | 167.51%160M | -98.40%6M | 89.22%-40M | 194.81%73M | -201.60%-382M | ---237M | --376M | ---371M | ---77M |
-Change in other current liabilities | -199.60%-252M | -81.79%51M | -18.18%-78M | -181.72%-152M | 50.34%-73M | 88.81%253M | --280M | ---66M | --186M | ---147M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 70.97%1.6B | 66.75%652M | -47.65%290M | 687.80%323M | 787.76%337M | -19.43%937M | --391M | --554M | --41M | ---49M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Capital expenditure reported | -42.16%-381M | -98.53%-135M | -36.92%-89M | -21.74%-84M | -10.61%-73M | -29.47%-268M | ---68M | ---65M | ---69M | ---66M |
Net PPE purchase and sale | 9.43%-144M | 35.96%-57M | -76.19%-37M | 9.68%-28M | -22.22%-22M | -38.26%-159M | ---89M | ---21M | ---31M | ---18M |
Net intangibles purchase and sale | 22.29%-136M | 120.97%13M | -52.94%-52M | -11.11%-40M | -32.56%-57M | -75.00%-175M | ---62M | ---34M | ---36M | ---43M |
Net business purchase and sale | ---160M | --0 | ---28M | ---25M | ---107M | --0 | --0 | --0 | --0 | --0 |
Net investment purchase and sale | --10M | --15M | ---5M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -34.72%-811M | 25.11%-164M | -75.83%-211M | -30.15%-177M | -103.94%-259M | 76.08%-602M | ---219M | ---120M | ---136M | ---127M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | -245.86%-264M | -103.10%-9M | 9.09%-10M | 49.49%-50M | -19,600.00%-195M | -91.15%181M | --290M | ---11M | ---99M | --1M |
Net common stock issuance | 5.03%-189M | -3,600.00%-210M | --0 | 104.29%7M | 1,300.00%14M | -3,416.67%-199M | --6M | ---43M | ---163M | --1M |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | 62.15%-95M | --0 | ---95M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -315.04%-469M | -176.01%-225M | 90.60%-14M | 81.30%-49M | -9,150.00%-181M | -106.34%-113M | --296M | ---149M | ---262M | --2M |
Net cash flow | ||||||||||
Beginning cash position | 9.40%3.27B | 26.25%3.41B | 24.52%3.24B | 11.12%3.16B | 9.40%3.27B | 11.53%2.99B | --2.7B | --2.6B | --2.84B | --2.99B |
Current changes in cash | 45.05%322M | -43.80%263M | -77.19%65M | 127.17%97M | 40.80%-103M | -48.25%222M | --468M | --285M | ---357M | ---174M |
Effect of exchange rate changes | -242.37%-84M | -260.78%-164M | 160.44%110M | -116.67%-19M | -144.00%-11M | 149.17%59M | --102M | ---182M | --114M | --25M |
End cash Position | 7.28%3.51B | 7.28%3.51B | 26.25%3.41B | 24.52%3.24B | 11.12%3.16B | 9.40%3.27B | --3.27B | --2.7B | --2.6B | --2.84B |
Free cash flow | 180.90%941M | 175.00%473M | -74.19%112M | 280.00%171M | 205.11%185M | -54.36%335M | --172M | --434M | ---95M | ---176M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |